Randomized, Placebo-Controlled, Phase I/II Trial Of The Thrombopoietin Receptor Agonist Eltrombopag In Thrombocytopenic Patients With Advanced Myelodysplastic Syndromes Or Acute Myeloid Leukemia — A Subgroup Analysis Of Patients Receiving Concomitant Anticancer Therapy
Year: 2013
Type: article
Source: Blood
Authors: Uwe Platzbecker, Raymond S.M. Wong, Amit Verma, Camille N. Abboud, Sergio Araujo, Tzeon-Jye Chiou, John Feigert, Su-Peng Yeh, Katharina Götze, Norbert Claude Gorin, Peter L. Greenberg, Suman Kambhampati, Yoo Jin Kim, Je-Hwan Lee, Roger M. Lyons, Marco Ruggeri, Valeria Santini, Gregory Cheng, Jun Ho Jang, Chien-Yuan Chen, Souria Hasan Dougherty, Frank Mannino, Yasser Mostafa Kamel, Geoffrey W. Chan, Nicole L. Stone, Aristoteles Giagounidis
Institutions: Technische Universität Dresden, Prince of Wales Hospital, Albert Einstein College of Medicine, Washington University in St. Louis, Universidade Federal de Minas Gerais, Hospital das Clínicas da Universidade Federal de Minas Gerais, Taipei Veterans General Hospital, Virginia Cancer Specialists, China Medical University Hospital, TUM Klinikum, Technical University of Munich, Inserm, Hôpital Saint-Antoine, Université Pierre-et-Marie-Curie, Stanford University, The University of Kansas Cancer Center, The Catholic University of Korea Seoul St. Mary's Hospital, Catholic University of Korea, Asan Medical Center, The US Oncology Network, Ospedale San Bortolo, University of Florence, Macau University of Science and Technology, Samsung Medical Center, Sungkyunkwan University, National Taiwan University Hospital, GlaxoSmithKline (United States), GlaxoSmithKline (United Kingdom), Marien Hospital Düsseldorf
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W110093125